title: Lipopolysaccharide-induced increases in cytokines in discrete mouse brain regions are detectable using Luminex xMAP technology.
abstract: Methods to determine cytokine protein content in samples of interest, such as enzyme-linked immunosorbent assay (ELISA), are often labor-intensive and costly. Furthermore, because ELISA requires relatively large sample volumes and protein concentrations, it is difficult using this technique to determine protein content for multiple cytokines from individual samples. Recently, Luminex has developed an open source hardware platform combining flow cytometry- and bead-based antibody capture that is capable of detecting multiple analytes from a single sample. In the present study we employed the Luminex 200 platform to determine the cytokine protein content in discrete brain regions of C57BL/6J mice. In spike-and-recovery experiments, known concentrations of murine recombinant interleukin (IL)-1beta, IL-6, and tumor necrosis factor (TNF)alpha were added either singly or as a mixture of all three to whole brain homogenates containing known quantities of total protein. Spiked samples were assayed for either a single cytokine or for multiple cytokines using 1-plex or 3-plex assay kits, respectively. In whole mouse brain homogenate we recovered between 81% and 103% of the recombinant cytokines. We then injected C57BL/6J mice intraperitoneally with bacterial lipopolysaccharide (LPS) and sacrificed them 4h later. We detected in samples taken from LPS-stimulated mice 4- to 870-fold increases in serum or spleen cytokine protein, and 1.5- to 16-fold increases in cytokine protein in discrete brain regions, relative to protein content in samples obtained from vehicle-treated animals. These results indicate that multiple cytokines may be reliably assayed from discrete regions of mouse brain using a single sample.
authors.affiliation: Department of Anesthesiology, University of Michigan, Ann Arbor, MI 48109, USA.
authors.forename: Subhash C
authors.initials: SC
authors.lastname: Datta
authors.forename: Mark R
authors.initials: MR
authors.lastname: Opp
mesh_terms: D000818:Animals; D001921:Brain / Q000033:anatomy & histology / Q000187:drug effects / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism*; D005786:Gene Expression Regulation / Q000187:drug effects*; D053583:Interleukin-1beta / Q000378:metabolism; D015850:Interleukin-6 / Q000378:metabolism; D008163:Luminescent Measurements / Q000295:instrumentation* / Q000379:methods; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D011134:Polysaccharides / Q000494:pharmacology*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D016207:Cytokines; D053583:Interleukin-1beta; D015850:Interleukin-6; D011134:Polysaccharides; D014409:Tumor Necrosis Factor-alpha
references.citation: J Appl Physiol (1985). 2002 Jun;92(6):2648-55
references.pmid: 12015385
references.citation: Physiol Rev. 1999 Jan;79(1):1-71
references.pmid: 9922367
references.citation: J Neurosci Methods. 2004 Jun 15;136(1):87-98
references.pmid: 15126049
references.citation: Cytometry B Clin Cytom. 2004 Sep;61(1):35-9
references.pmid: 15351980
references.citation: Am J Clin Pathol. 2002 Sep;118(3):346-53
references.pmid: 12219776
references.citation: J Endocrinol Invest. 2001 Nov;24(10):786-95
references.pmid: 11765048
references.citation: Clin Diagn Lab Immunol. 2003 Jan;10(1):133-9
references.pmid: 12522051
references.citation: J Neurotrauma. 2007 Nov;24(11):1707-17
references.pmid: 18001201
references.citation: Neuroimmunomodulation. 1998 May-Aug;5(3-4):160-5
references.pmid: 9730681
references.citation: Brain Behav Immun. 2004 May;18(3):274-80
references.pmid: 15050654
references.citation: J Immunol. 1991 Apr 1;146(7):2316-23
references.pmid: 2005401
references.citation: Glia. 2007 Apr 1;55(5):453-62
references.pmid: 17203472
references.citation: Neurol Clin. 2006 Aug;24(3):441-60
references.pmid: 16877117
references.citation: Sleep Med Rev. 2005 Oct;9(5):355-64
references.pmid: 16102986
references.citation: Cytokine. 2005 Dec 7;32(5):194-8
references.pmid: 16257531
references.citation: J Immunol Methods. 2005 Jul;302(1-2):172-81
references.pmid: 16023134
references.citation: Cytokine. 2000 Aug;12(8):1205-10
references.pmid: 10930297
references.citation: J Neuroimmunol. 2007 Sep;189(1-2):41-9
references.pmid: 17655939
references.citation: Physiol Res. 2003;52(5):593-8
references.pmid: 14535835
references.citation: Clin Chem. 2005 Jul;51(7):1102-9
references.pmid: 15976097
references.citation: J Inflamm (Lond). 2006 Nov 29;3:15
references.pmid: 17134510
references.citation: Am J Pathol. 1991 Feb;138(2):395-402
references.pmid: 1992764
references.citation: Mol Med. 1997 Dec;3(12):864-75
references.pmid: 9440119
references.citation: Clin Diagn Lab Immunol. 2002 Jul;9(4):872-6
references.pmid: 12093688